Emergent BioSolutions (EBS) Other Working Capital Changes (2010 - 2026)

Emergent BioSolutions' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 133.68% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $1.0 million (up 109.9% YoY), while the FY2025 annual figure was -$11.7 million, up 42.36% from the prior year.
• Other Working Capital Changes was $3.2 million for Q1 2026 at Emergent BioSolutions, up from -$12.8 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.3 million in Q2 2023 to a low of -$25.0 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged -$2.6 million across 5 years, with a median of $500000.0 in 2023.
• Biggest YoY gain for Other Working Capital Changes was 4600.0% in 2025; the steepest drop was 753.33% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$25.0 million in 2022, then jumped by 50.4% to -$12.4 million in 2023, then surged by 87.9% to -$1.5 million in 2024, then tumbled by 753.33% to -$12.8 million in 2025, then jumped by 125.0% to $3.2 million in 2026.
• The last three Other Working Capital Changes figures came in at $3.2 million (Q1 2026), -$12.8 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.